Impact of mental health comorbidities on health care utilization and expenditure in a large US managed care adult population with ADHD

Value in Health

Volumn 17, Issue 6, 2014, Pages 661-668

  Kawatkar, Aniket A ^a   Knight, Tara K ^b   Moss, Robert A ^a   Sikirica, Vanja ^c   Chu, Li Hao ^a   Hodgkins, Paul ^c   Haim Erder, M ^c   Nichol, Michael B ^b  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c SHIRE   (United States)

Author keywords

ADHD; comorbidity; expenditure; mental health; utilization

Indexed keywords

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; COMORBIDITY; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; UNITED STATES; ADOLESCENT; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COHORT ANALYSIS; ECONOMICS; EPIDEMIOLOGY; HEALTH INSURANCE; HEALTH SURVEY; MIDDLE AGED; PATIENT ATTITUDE; PROCEDURES; PSYCHOLOGY; RETROSPECTIVE STUDY; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CALIFORNIA; COHORT STUDIES; COMORBIDITY; FEMALE; HEALTH EXPENDITURES; HUMANS; MALE; MANAGED CARE PROGRAMS; MENTAL HEALTH; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84908205653     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2014.06.002     Document Type: Article

References (35)

1. Adler L, Cohen J. Diagnosis and evaluation of adults with attentionde- defitcit/hyperactivity disorder. Psychiatr Clin North Am 2004;27:187-201.
2. Biederman J. Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2004;65(Suppl. 3):3-7.
3. Mannuzza S, Klein RG, Bessler A, et al. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 1998;155:493-8.
4. Wilens TE, Faraone SV, Biederman J. Attention-deficit/hyperactivity disorder in adults. JAMA 2004;292:619-23.
5. Pary R, Lewis S, Matuschka PR, et al. Attention deficit disorder in adults. Ann Clin Psychiatry 2002;14:105-11.
6. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-23.
7. Arseneault L, Moffitt TE, Caspi A, et al. Mental disorders and violence in a total birth cohort: results from the Dunedin Study. Arch Gen Psychiatry 2000;57:979-86.
8. Secnik K, Swensen A, Lage MJ. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics 2005;23:93-102.
9. Birnbaum HG, Kessler RC, Lowe SW, et al. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin 2005;21:195-206.
10. Hodgkins P, Montejano L, Sasane R, et al. Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis. Prim Care Companion CNS Disord 2011;13: PCC.10M01030.
11. Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405-18.
12. Rice DP, Kelman S, Miller LS. Estimates of economic costs of alcohol and drug abuse and mental illness, 1985 and 1988. Public Health Rep 1991;106:280-92.
13. Burd L, Klug MG, Coumbe MJ, et al. The attention-deficit hyperactivity disorder paradox, 2: phenotypic variability in prevalence and cost of comorbidity. J Child Neurol 2003;18:653-60.
14. Swensen AR, Birnbaum HG, Secnik K, et al. Attention-deficit/hyperactivity disorder: increased costs for patients and their families. J Am Acad Child Adolesc Psychiatry 2003;42:1415-23.
15. Seidman LJ, Biederman J, Weber W, et al. Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biol Psychiatry 1998;44:260-8.
16. Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry 1996;37:393-401.
17. Koebnick C, Langer-Gould AM, Gould MK, et al. Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Permanente J 2012;16:37-41.
18. Hsiao WC, Braun P, Becker ER, et al. The Resource-Based Relative Value Scale: toward the development of an alternative physician payment system. JAMA 1987;258:799-802.
19. CMS. Federal Register Rules and Regulations. In: Services CfMM, ed. Washington, DC: Government Printing Office, 2008.
20. Bureau of Labor Statistics. Consumer Price Index 2010.
21. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
22. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for de.ning comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9.
23. Leibson CL, Barbaresi WJ, Ransom J, et al. Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment. Ambul Pediatr 2006;6:45-53.
24. Leibson CL, Katusic SK, Barbaresi WJ, et al. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA 2001;285:60-6.
25. American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the schoolaged child with attention-deficit/hyperactivity disorder. Pediatrics 2001;108:1033-44.
26. Leibson CL, Long KH. Economic implications of attention-deficit hyperactivity disorder for healthcare systems. Pharmacoeconomics 2003;21:1239-62.
27. Fishman PA, Stang PE, Hogue SL. Impact of comorbid attention deficit disorder on the direct medical costs of treating adults with depression in managed care. J Clin Psychiatry 2007;68:248-53.
28. Hinnenthal JA, Perwien AR, Sterling KL. A comparison of service use and costs among adults with ADHD and adults with other chronic diseases. Psychiatr Serv 2005;56:1593-9.
29. Chan E, Zhan C, Homer CJ. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey. Arch Pediatr Adolesc Med 2002;156:504-11.
30. Guevara J, Lozano P, Wickizer T, et al. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics 2001;108:71-8.
31. Swensen A, Birnbaum HG, Ben Hamadi R, et al. Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. J Adolesc Health 2004;35(346):e1-9.
32. Stein BD, Meili R, Tanielian TL, et al. Outpatient mental health utilization among commercially insured individuals: in- and out-of-network care. Med Care 2007;45:183-6.
33. Pugh MJ, Zeber JE, Copeland LA, et al. Psychiatric disease burden pro.les among veterans with epilepsy: the association with health services utilization. Psychiatr Serv 2008;59:925-8.
34. Fletcher JM. The effects of childhood ADHD on adult labor market outcomes. Health Econ 2014;23:159-81.
35. Zuvekas SH, Fleishman JA. Self-rated mental health and racial/ethnic disparities in mental health service use. Med Care 2008;46:915-23.